Shares Of Endo International $ENDP May Have 50% Upside, Note This Chart...

In recent weeks, pharma plays like Valeant Pharmaceuticals Intl (VRX) and Teva Pharmaceutical Industries (TEVA) have surged. Valeant is up almost 100% since October and Teva is up almost 50%. In other words, pharma has become a hot sector as Trump's corporate tax cuts near finalization. One pharma stock that is lagging but has a gorgeous bull flag is Endo International (NASDAQ:ENDP). I have placed this one on my watch list. Should the bull flag start to breakout with price pushing over $7.75, it becomes a strong buy with major upside potential. The upside potential target is $10.65. This would be a catch-up trade to the other pharma plays like Valeant and Teva.





Gareth Soloway

InTheMoneyStocks